找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: ;

[復(fù)制鏈接]
樓主: 貶損
31#
發(fā)表于 2025-3-27 00:34:43 | 只看該作者
Federal Republic of Germany: Neuroleptic Relapse Preventionfrequent episodical relapses. Without neuroleptic therapy about 40%-70% of schizophrenic patients relapsed within 2 years following the first psychotic episode. In the FRG, these facts were the reason for changing from short-term neuroleptic therapy to long-term treatment. The aims of the long-term use of neuroleptics (NL) are:
32#
發(fā)表于 2025-3-27 02:07:09 | 只看該作者
33#
發(fā)表于 2025-3-27 05:25:24 | 只看該作者
34#
發(fā)表于 2025-3-27 12:02:36 | 只看該作者
Duration of Neuroleptic Maintenance Treatmentatients are to receive this maintenance treatment (see review by Johnson, this volume) as well as the question whether reliable predictors of the individual relapse risk are available (see review by Marder, this volume). Thus a certain amount of overlap with these other reviews cannot be avoided.
35#
發(fā)表于 2025-3-27 13:39:47 | 只看該作者
36#
發(fā)表于 2025-3-27 19:30:17 | 只看該作者
Sweden: Neuroleptic Relapse PreventionSwedish psychiatry is sectorized. That usually means the total responsibility for all the various types of mental disorders lies within a catchment area. Within such a catchment area the in- and outpatient care is coordinated with the use of ward units as well as clinics.
37#
發(fā)表于 2025-3-28 00:04:29 | 只看該作者
38#
發(fā)表于 2025-3-28 05:37:26 | 只看該作者
39#
發(fā)表于 2025-3-28 10:12:58 | 只看該作者
Austria: The Current Status of Maintenance Treatment in Schizophreniaut 20% of all acute hospital admissions, while the percentage of schizophrenics in long-stay units probably exceeds 30%. Twenty-nine neuroleptics of the various chemical classes are currently registered and marketed in Austria. Four of these (haloperidol, fluphenazine, flupenthixol and clopenthixol)
40#
發(fā)表于 2025-3-28 12:45:08 | 只看該作者
United Kingdom: Neuroleptic Relapse Prevention(Davis 1975). Attempts to produce clear guidelines or recommendations for relapse prevention may currently be confounded by our scant knowledge regarding basic issues such as the relative value of oral and depot preparations in this regard; whether particular drugs, classes of drugs or dose regimes
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 07:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
池州市| 阳高县| 徐水县| 灌阳县| 平顶山市| 固镇县| 三门峡市| 武威市| 南投市| 托克托县| 屯留县| 台东市| 河北区| 富蕴县| 工布江达县| 十堰市| 峨边| 班玛县| 云南省| 辉南县| 同心县| 安阳县| 邢台县| 泗水县| 红桥区| 德清县| 水富县| 库伦旗| 枝江市| 永济市| 郴州市| 吴桥县| 延寿县| 宁阳县| 宁明县| 澄城县| 沙坪坝区| 盘锦市| 新乡县| 益阳市| 建湖县|